Skip to main content
. Author manuscript; available in PMC: 2014 Apr 4.
Published in final edited form as: J Urol. 2012 Aug 15;188(4):1131–1136. doi: 10.1016/j.juro.2012.06.009

Table 2.

Cox proportional hazards models and concordance indices to predict biopsy reclassification during active surveillance using (a) baseline and (b) longitudinal measurements of total PSA, %fPSA, %[-2]proPSA, [-2]proPSA/%fPSA, and phi after adjusting for age, date of diagnosis, and PSA density (n=167; 63 biopsy reclassification events).

(a)
Cox Proportional Hazards Models
HR (95% CI) P-value C-index
Baseline tPSA 0.90 (0.80-1.00) 0.061 0.630
Baseline %fPSA 0.93 (0.89-0.97) 0.002 0.664
Baseline %[-2]proPSA 2.44 (1.51-3.94) <0.0001 0.651
Baseline [-2]proPSA/%fPSA 2.13 (1.09-4.16) 0.026 0.652
Baseline phi 1.04 (1.02-1.06) <0.0001 0.662
(b)
Cox Proportional Hazards Models
HR (95% CI) P-value C- index
Longitudinal tPSA 0.96 (0.88-1.05) 0.366 0.703
Longitudinal %fPSA 0.94 (0.90-0.98) 0.002 0.722
Longitudinal %[-2]proPSA 1.92 (1.36-2.73) <0.0001 0.647
Longitudinal [-2]proPSA/%fPSA 2.12 (1.25-3.59) 0.005 0.654
Longitudinal phi 1.04 (1.02-1.06) <0.0001 0.635